ISRCTN96782911进行中（未招募）Unknown
ong-term observational follow-up of participants treated in the GLAUrious trial
BELKIN Vision0 个研究点目标入组 192 人开始时间: 2023年7月23日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 192
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •Participants enrolled to the GLAUrious study and treated with either the SLT or DSLT between November 2018 and May 2021
排除标准
- •Participants who were not enrolled to the GLAUrious study and treated with either the SLT or DSLT between November 2018 and May 2021
研究者
相似试验
进行中（未招募）
1 期
ong term follow-up study of gene therapy trial for X-linked Retinitis PigmentosaEUCTR2018-000425-31-Outside-EU/EEAJanssen-Cilag International NV
进行中（未招募）
1 期
ong term follow-up study of gene therapy trial for X-linked Retinitis PigmentosaX-Linked Retinitis Pigmentosa caused by mutations in the RPGR geneMedDRA version: 20.0 Level: PT Classification code 10038914 Term: Retinitis pigmentosa System Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2018-000425-31-GBMeiraGTx UK II Ltd36
进行中（未招募）
1 期
ong term follow-up study of gene therapy trial for LCA2 OPTIRPE65eber Congenital Amaurosis (LCA) caused by mutations in RPE65MedDRA version: 20.0Level: PTClassification code 10070667Term: Leber's congenital amaurosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2016-000898-20-GBMeiraGTx UK Ltd27
进行中（未招募）
1 期
ong-term follow-up gene therapy study for Achromatopsia (CNGB3)Achromatopsia caused by mutations in the CNGB3 geneMedDRA version: 19.1 Level: LLT Classification code 10000454 Term: Achromatopsia System Organ Class: 100000004850EUCTR2016-003856-59-GBMeiraGTX UK II Ltd27
招募中
不适用
The observational study for the long-term follow-up of the participants of the preceding study "Prevention of Type II Endoleak with Embolization of IMA Before Endovascular Aneurysm Repair"Abdominal aortic aneurysmJPRN-UMIN000047713Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine86